Self-Care and Quality of Life in Elderly Chinese Patients with Benign Prostatic Hyperplasia

Tong, Yongcheng; Xie, Keqin; Li, Shuxia

doi:10.1177/0894318419883417

Cited by 7 publications

(4 citation statements)

References 16 publications

(13 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Some studies have demonstrated that patients with BPH and ED show social and emotional difficulties, such as anxiety, depression, social isolation and pain that can result in fatigue, decreased vitality and insomnia, with a decrease in quality of life 2,3 . On the other hand, the prevalence of ED is age-dependent and increases from 5% in patients aged 40 years to 15% in those older than 70 years.…”

Section: Introductionmentioning

confidence: 99%

Quality of life and erectile dysfunction in patients with benign prostatic hyperplasia

Montiel-Jarquín¹,

Gutiérrez-Quiroz²,

Pérez-Vázquez³

et al. 2023

CIRUE

View full text Add to dashboard Cite

Background:The most frequent prostatic pathology is benign prostatic hyperplasia. By the age of 50, 50% are diagnosed with it and by the age of 80, it increases to 90%. The erectile dysfunction prevalence along benign prostatic hyperplasia is 5.2%-40%. Patients with benign prostatic hyperplasia are 1.33-6.24 times more likely to have erectile dysfunction than without benign prostatic hyperplasia. Objective: To identify quality of life and to grade erectile dysfunction in patients with benign prostatic hyperplasia. Method: A transversal, descriptive study was conducted in patients with benign prostatic hyperplasia. Two questionnaires were applied: SF-12 for quality of life and IIEF-5 for erectile dysfunction. Results: 101 patients, mean age 66.5 ± 8.5 years, mean physical aspect 38.68, mean mental aspect 43.35, 14 without erectile dysfunction, 38 mild grade, 33 mild to moderate, 15 moderate and 1 severe. Conclusions: Benign prostatic hyperplasia patients have poor physical health and good mental health. 70.3% of patients have a grade of erectile dysfunction between mild and mild-moderate.

show abstract

Section: Introductionmentioning

confidence: 99%

Quality of life and erectile dysfunction in patients with benign prostatic hyperplasia

Montiel-Jarquín¹,

Gutiérrez-Quiroz²,

Pérez-Vázquez³

et al. 2023

CIRUE

View full text Add to dashboard Cite

show abstract

“…Tong ve ark. yaptıkları çalışmada en sık semptomların idrara sık gitme, aniden idrara gitme isteği, inkontinans ve dizüri olduğunu saptamışlar ve bu semptomların hayat kalitesine toplam etkisini %70 olarak bildirmişlerdir (12). Bu bulgulara göre bu hastalarda uygulanacak tedaviler alt üriner sistem semptomlarının sayısını ve derecesini azaltmayı hedef almalıdır.…”

Section: Anket çAlışmasıunclassified

Symptoms of Lower Urinary Tract and Their Effect on Life Quality in Males Over 50

2021

View full text Add to dashboard Cite

Çalışmamızda 50 yaş üzeri erkeklerde ortaya çıkan alt üriner sistem semptomlarını, bu semptomların yaşam kalitesini etkileme derecesini araştırmayı amaçladık. Materyal ve Metot: Çalışmaya İstanbul il Sağlık Müdürlüğüne bağlı Ümraniye 1 nolu Aile Sağlığı Merkezi'ne 01.01.2020-01.03.2020 tarih aralığında başvuran 50 yaş üstü 307 erkek hasta dahil edildi. Onamları alınarak çalışmaya dahil edilen tüm hastalara 23 soruluk anket uygulandı. Anketteki soruların bir kısmı alt üriner sistem semptomlarının varlığı ve bu semptomların hastalara psikolojik, sosyal, fiziksel ve cinsel etkilerine yönelik sorular; diğerleri de hastaların özgeçmiş bilgilerine yönelik sorulardı. Bulgular: Yaşam kalitesi skoruna göre yapılan gruplamada hastaların 292'sinin (%95,1) yüksek, 14'ünün (%4,6) orta, birinin (%0,3) düşük yaşam kalitesi grubunda olduğu görüldü. Ortalama toplam yaşam kalitesi skoru %92,1±12,3 olarak belirlendi. Ortalama psikolojik skor %81,1±14,4, sosyal skor ise %90,0±20,8 olarak saptandı. Her bir şikâyet için; şikayeti olan hastalardaki yaşam kalitesi skoru, psikolojik, fiziksel, sosyal ve cinsel skorların her birisi şikayeti olmayanlara göre anlamlı düşük bulundu (Her birisi için p<0,001). Yapılan korelasyon analizlerinde yaş ile toplam yaşam kalitesi, cinsel, psikolojik ve sosyal skorlar arasında anlamlı ters korelasyon olduğu görüldü (Her biri için p<0,05). Sonuç: Alt üriner sistem semptomları 50 yaş üzeri erkeklerin yaşam kalitesini olumsuz yönde etkilemektedir. Bu hastaların hem alt üriner sistem şikâyetlerinin azaltılmasına yönelik tedavilerin düzenlenmesi, hem de psikolojik, sosyal ve cinsel yönlerden destekleyici uygulamaların yapılması gereklidir.Anahtar Kelimeler: Alt üriner sistem; benign prostat hiperplazisi; benign prostat hiperplazisi yaşam kalitesi ölçeği (bph-yk); yaşam kalitesi Abstract Aim: WAim: We aimed to investigate the lower urinary tract symptoms of men over 50 years and to what extent these symptoms affect the quality of life of patients. Material and Methods:The study included 307 male patients over the age of 50 who applied to Umraniye 1 Family Health Center between 01.01.2020-01.03.2020. All the patients included in the study were applied a questionnaire of 23 questions which are about low urinary tract system symptoms and regarding the psychological, social, physical and sexual effects of these symptoms on patients. Results: According to the quality of life scores, 292 (95.1%) of the patients were in the high, 14 (4.6%) were in the middle and one (0.3%) were in the low quality of life. The mean total quality of life score was 92.1 ± 12.3% . The mean total psychological score was 81.1 ± 14.4%, and the social score was 90.0 ± 20.8%. For each complaint; The mean total quality of life score, psychological, physical, social and sexual scores of patients with complaints were significantly lower than those without complaints (p <0.001 for each). In correlation analysis, there was a significant inverse correlation between age and total quality of life, sexual, psychological and social scores (p <0.05 fo...

show abstract

“…This disorder is characterized by a non-malignant enlargement of the prostate gland that is due to the proliferation of epithelial and stromal cells in this gland ( 2 , 3 ). BPH is associated with an increased smooth muscle tone and obstruction of the proximal urethra leading to increased urinary frequency, nocturia, urinary incontinence, and voiding (slow and/or weak stream); all of these symptoms decrease the quality of life of patients considerably ( 3 , 4 ).…”

Section: Introductionmentioning

confidence: 99%

FruHis significantly increases the anti-benign prostatic hyperplasia effect of lycopene: A double-blinded randomized controlled clinical trial

Sadeghi

Saedisomeolia²,

Jalili‐Baleh³

et al. 2022

Front. Nutr.

View full text Add to dashboard Cite

BackgroundFor decades, lycopene was considered the main compound of tomato protecting benign prostatic hyperplasia (BPH). Recent animal studies suggest that a newly discovered compound “FruHis” boosts lycopene for its action. This study aimed to determine whether FruHis enhances the action of lycopene to modify the laboratory parameters and clinical outcomes of patients with BPH.Materials and methodsCurrent study was conducted on 52 BPH patients, who were randomly assigned into four groups of treatments: lycopene plus FruHis (n = 11, 25 mg/day lycopene and 10 mg/day FruHis), lycopene (n = 12, 25 mg/day lycopene), FruHis (n = 12, 10 mg/day FruHis), and placebo (n = 13). Patients received these supplements for 8 weeks.ResultsFruHis intake strengthened the reducing effects of lycopene on insulin-like growth factor-1 (IGF-1) (−54.47 ± 28.36 ng/mL in the lycopene + FruHis group vs. −30.24 ± 46.69 ng/mL in the lycopene group), total prostate-specific antigen (TPSA) (−1.49 ± 4.78 ng/mL in the lycopene + FruHis group vs. −0.64 ± 2.02 ng/mL in the lycopene group), and symptom score (−4.45 ± 4.03 in the lycopene + FruHis group vs. −1.66 ± 5.41 in the lycopene group) in BPH patients. Such findings were also seen for body mass index (BMI) and waist circumference (WC). However, except for IGF-1, these reductions were not statistically significant compared with the placebo, and the intakes of lycopene and FruHis alone, however, were clinically important. Such effects of lycopene and FruHis were not seen for free PSA (FPSA) and FPSA/TPSA ratio.ConclusionDespite the non-significant effects of lycopene and FruHis, it seems that FruHis intake strengthens the beneficial effects of lycopene on IGF-1, TPSA, and symptom scores among BPH patients.Clinical trial registration[www.irct.ir], identifier [IRCT20190522043669N1].

show abstract

Self-Care and Quality of Life in Elderly Chinese Patients with Benign Prostatic Hyperplasia

Cited by 7 publications

References 16 publications

Quality of life and erectile dysfunction in patients with benign prostatic hyperplasia

Quality of life and erectile dysfunction in patients with benign prostatic hyperplasia

Symptoms of Lower Urinary Tract and Their Effect on Life Quality in Males Over 50

FruHis significantly increases the anti-benign prostatic hyperplasia effect of lycopene: A double-blinded randomized controlled clinical trial

Contact Info

Product

Resources

About